VRTS vs WST · P/E 8.5, rev $400.9M vs P/E 35, rev $1.72B
Virtus Investment Partners, Inc. (VRTS) versus West Pharmaceutical Services Inc (WST) — a side-by-side from cached financials, not a winner call.
Virtus Investment Partners, Inc. (VRTS) is a asset management company listed on NYSE.
West Pharmaceutical Services Inc (WST) is a medical instruments & supplies company listed on US.
Latest reported VRTS revenue for 2026-06-30 was $400.9M. Net income was $50.8M. VRTS currently screens at market cap $957.7M and trailing P/E 8.5.
Latest reported WST revenue for 2026-06-30 was $1.72B. Net income was $292.8M. WST currently screens at market cap $15.97B and trailing P/E 34.8.
VRTS currently screens at market cap $957.7M and trailing P/E 8.5. WST currently screens at market cap $15.97B and trailing P/E 34.8.
Not investment advice. Open the VRTS and WST stock pages for the full models.
Not investment advice.